Annex 5
British Biotech
Dr Peter J Lewis
Oxford, England
Fax 011-44-1865
Dear Peter
I have been absolutely astounded with the recent
allegations by Andy Millar that you had been aware of unblinded
results from the USA Zacutex (R) phase III trials as far back
as the end of 1996. For the record, I would like to state that
as President of British Biotech Inc, the USA operating arm of
the company that has responsibility for running this trial, at
no time did you ever indicate to me that you ever had any knowledge
of the results, ie unblinded, of this trial.
As you were the Oxford executive responsible
for British Biotech Inc in Annapolis, you and I had frequent conversations
about the US clinical trials and the operations of the company
in general. As my then supervisor (and friend and colleague over
a 15 year period) we certainly shared a number of candid observations
about the company as a whole, its future, and its problems, serious
and not so serious. However, at no time did you ever give me the
slightest indication that you had any idea of the results of the
phase III Zacutex (R) trial.
Our relationship with each other has been fairly
close, and frankly, if you had been aware of any of this confidential
data or that Dr Millar had been unblinding this study, I am sure
that you would have given me some inkling of what was going on.
I will state categorically that you never, ever
gave me the slightest indication that you had any knowledge of
these results whatsoever, and I am certainly prepared to go on
record to this effect.
Yours sincerely
Peter P McCann, PhD, President
29 May 1998
|
